Log in
NASDAQ:CLXT

Calyxt Stock Forecast, Price & News

$3.31
-0.28 (-7.80 %)
(As of 10/28/2020 12:00 AM ET)
Add
Compare
Today's Range
$3.29
Now: $3.31
$3.55
50-Day Range
$3.46
MA: $5.20
$6.38
52-Week Range
$2.40
Now: $3.31
$8.41
Volume172,133 shs
Average Volume113,501 shs
Market Capitalization$109.84 million
P/E RatioN/A
Dividend YieldN/A
Beta2.29
Calyxt, Inc., a technology company, focuses on delivering plant-based solutions in the United States. The company offers high oleic soybean products, including oil and meal. It also develops high fiber wheat; improved digestibility alfalfa; and cold storable potatoes. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was founded in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.
Read More
Calyxt logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.1Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.84 out of 5 stars

Industry, Sector and Symbol

Industry Agricultural chemicals
Sub-IndustryN/A
Current SymbolNASDAQ:CLXT
CUSIPN/A
Phone651-683-2807
Employees75

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.30 million
Book Value$1.90 per share

Profitability

Net Income$-39,610,000.00
Net Margins-392.49%

Miscellaneous

Market Cap$109.84 million
Next Earnings Date11/5/2020 (Confirmed)
OptionableNot Optionable
$3.31
-0.28 (-7.80 %)
(As of 10/28/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CLXT News and Ratings via Email

Sign-up to receive the latest news and ratings for CLXT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Calyxt (NASDAQ:CLXT) Frequently Asked Questions

How has Calyxt's stock price been impacted by COVID-19?

Calyxt's stock was trading at $3.34 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CLXT shares have decreased by 0.9% and is now trading at $3.31.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Calyxt?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Calyxt in the last year. There are currently 5 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Calyxt
.

When is Calyxt's next earnings date?

Calyxt is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Calyxt
.

How can I listen to Calyxt's earnings call?

Calyxt will be holding an earnings conference call on Thursday, November 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Calyxt's earnings last quarter?

Calyxt, Inc. (NASDAQ:CLXT) issued its quarterly earnings data on Wednesday, August, 5th. The company reported ($0.33) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.36) by $0.03. The company earned $2.31 million during the quarter. Calyxt had a negative return on equity of 77.67% and a negative net margin of 392.49%.
View Calyxt's earnings history
.

What price target have analysts set for CLXT?

6 brokers have issued 12-month price targets for Calyxt's shares. Their forecasts range from $4.00 to $10.00. On average, they expect Calyxt's share price to reach $7.20 in the next year. This suggests a possible upside of 117.5% from the stock's current price.
View analysts' price targets for Calyxt
.

Are investors shorting Calyxt?

Calyxt saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 643,500 shares, an increase of 30.8% from the September 30th total of 491,900 shares. Based on an average daily volume of 140,300 shares, the days-to-cover ratio is currently 4.6 days. Approximately 6.3% of the company's stock are short sold.
View Calyxt's Short Interest
.

Who are some of Calyxt's key competitors?

What other stocks do shareholders of Calyxt own?

Who are Calyxt's key executives?

Calyxt's management team includes the following people:
  • Mr. James A. Blome, Chief Exec. Officer (Age 57, Pay $1.58M)
  • Mr. William F. Koschak, Chief Financial Officer (Age 51, Pay $659.15k)
  • Ms. Debra H. Frimerman, Gen. Counsel & Corp. Sec. (Age 40, Pay $452.91k)
  • Dr. Daniel F. Voytas Ph.D., Founder & Chief Science Officer (Age 57)
  • Dr. Travis J. Frey Ph.D., Chief Technology Officer (Age 42)

When did Calyxt IPO?

(CLXT) raised $101 million in an IPO on Thursday, July 20th 2017. The company issued 6,100,000 shares at a price of $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities acted as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers.

What is Calyxt's stock symbol?

Calyxt trades on the NASDAQ under the ticker symbol "CLXT."

How do I buy shares of Calyxt?

Shares of CLXT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Calyxt's stock price today?

One share of CLXT stock can currently be purchased for approximately $3.31.

How big of a company is Calyxt?

Calyxt has a market capitalization of $109.84 million and generates $7.30 million in revenue each year. The company earns $-39,610,000.00 in net income (profit) each year or ($1.21) on an earnings per share basis. Calyxt employs 75 workers across the globe.

What is Calyxt's official website?

The official website for Calyxt is www.calyxt.com.

How can I contact Calyxt?

Calyxt's mailing address is 2800 MOUNT RIDGE ROAD, ROSEVILLE MN, 55113. The company can be reached via phone at 651-683-2807 or via email at [email protected]

This page was last updated on 10/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.